Raptor Pharmaceutica (RPTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,383 | 28,757 | 10,091 | 28,780 | 3,021 |
| Marketable Securities | N/A | N/A | 80,500 | N/A | N/A |
| Receivables | N/A | N/A | 2,479 | N/A | 3,415 |
| Inventories | N/A | N/A | 246 | N/A | N/A |
| Other current assets | 0 | 0 | 141 | 0 | 1,461 |
| TOTAL | $55,964 | $29,424 | $93,457 | $28,780 | $7,897 |
| Non-Current Assets | |||||
| PPE Net | 796 | 1,301 | 116 | 24 | 37 |
| Investments And Advances | 2,719 | 0 | 0 | 0 | 0 |
| Intangibles | 3,906 | 0 | 995 | 0 | 0 |
| Other Non-Current Assets | 50 | 380 | 6,826 | 11 | 50 |
| TOTAL | $7,471 | $1,680 | $7,937 | $35 | $87 |
| Total Assets | $63,435 | $31,104 | $101,394 | $28,815 | $7,984 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,201 | 976 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,254 | 3,641 | 6,365 | 1,284 | 724 |
| Accrued Expenses | N/A | N/A | 2,386 | 880 | 611 |
| Other current liabilities | 4,815 | N/A | N/A | N/A | N/A |
| TOTAL | $12,270 | $4,618 | $8,911 | $2,164 | $1,335 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,397 | 3,826 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 72,018 | 5,945 | 0 | 0 |
| TOTAL | $6,596 | $84,828 | $5,945 | $N/A | $N/A |
| Total Liabilities | $18,866 | $89,445 | $14,856 | $2,164 | $1,335 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 923 | 395 | 394 | 353 | 174 |
| Common Shares | 16 | 1 | 54 | 34 | 24 |
| Retained earnings | -73,032 | -58,850 | -62,508 | -33,728 | -25,622 |
| Other shareholders' equity | 168 | -211 | -158 | 0 | -8 |
| TOTAL | $44,569 | $-58,341 | $86,538 | $26,651 | $6,649 |
| Total Liabilities And Equity | $63,435 | $31,104 | $101,394 | $28,815 | $7,984 |